Ignite Creation Date:
2025-12-24 @ 5:31 PM
Ignite Modification Date:
2026-04-05 @ 4:26 PM
Study NCT ID:
NCT07154368
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-09-19
First Post:
2025-08-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
JYP0322 Versus Platinum Based Doublet Chemotherapy in ROS1 Positive Patients Previously Treated With ROS1-TKIs.
Sponsor:
Guangzhou JOYO Pharma Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-09-23
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-08-19
First Submit QC Date:
None
Study First Post Date:
2025-09-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-17
Last Update Post Date:
2025-09-19
Last Update Post Date Type:
ESTIMATED